Back to top
Ralosto 60 mg Tablet
Ralosto 60 mg Tablet

Ralosto 60 mg Tablet

Ralosto 60 mg Tablet Specification

  • Origin of Medicine
  • Synthetic
  • Pacakaging (Quantity Per Box)
  • 30 tablets
  • Salt Composition
  • Raloxifene Hydrochloride
  • Drug Type
  • Pharmaceutical
  • Ingredients
  • Raloxifene Hydrochloride
  • Physical Form
  • Tablet
  • Function
  • Used to prevent and treat osteoporosis in postmenopausal women; may also reduce the risk of invasive breast cancer in women at high risk.
  • Recommended For
  • Postmenopausal women for the treatment of osteoporosis or breast cancer prevention
  • Dosage
  • 60 mg per tablet
  • Dosage Guidelines
  • Take one tablet daily preferably at the same time each day as directed by your healthcare provider.
  • Suitable For
  • Adults (especially postmenopausal women)
  • Quantity
  • 30 tablets per pack
  • Storage Instructions
  • Store in a cool dry place below 30C. Keep away from direct sunlight and moisture.
 
 

About Ralosto 60 mg Tablet



Ralosto 60 mg Tablet is a pharmaceutical drug containing Raloxifene Hydrochloride as its active ingredient. Each pack contains 30 tablets, with each tablet providing 60 mg of dosage. This medication is designed for postmenopausal women to prevent and treat osteoporosis and reduce the risk of invasive breast cancer in high-risk women. Recommended for adults, especially postmenopausal women, the tablet should be taken once daily at the same time as prescribed by a healthcare provider. Originating as a synthetic medicine, Ralosto is suitable for those seeking osteoporosis treatment or breast cancer prevention. Remember to store the tablets in a cool, dry place below 30C, away from direct sunlight and moisture.

FAQs of Ralosto 60 mg Tablet:


Q: What is Ralosto 60 mg Tablet used for?

A: Ralosto 60 mg Tablet is used to prevent and treat osteoporosis in postmenopausal women and may also reduce the risk of invasive breast cancer in high-risk women.

Q: How should I take Ralosto 60 mg Tablet?

A: Take one tablet daily at the same time each day as directed by your healthcare provider.

Q: Who is Ralosto 60 mg Tablet suitable for?

A: Ralosto 60 mg Tablet is suitable for adults, especially postmenopausal women.

Q: What is the recommended storage condition for Ralosto 60 mg Tablet?

A: Store Ralosto 60 mg Tablet in a cool, dry place below 30C, away from direct sunlight and moisture.

Q: How many tablets are there in one pack of Ralosto 60 mg Tablet?

A: Each pack of Ralosto 60 mg Tablet contains 30 tablets.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Osteoporsis Category

Bandrone 50 mg Tablet

Bandrone 50 mg Tablet

Origin of Medicine : Synthetic

Physical Form : Tablet, Other

Recommended For : Individuals with osteoporosis particularly postmenopausal women

Quantity : 1 strip of 4 tablets

Function : Prevention and treatment of osteoporosis reducing bone loss, Other

Ingredients : Ibandronic Acid

Bonrise 150 mg Tablet

Bonrise 150 mg Tablet

Origin of Medicine : Synthetic

Physical Form : Tablet, Other

Recommended For : Postmenopausal women who are at risk of developing osteoporosis or require treatment for existing osteoporosis.

Quantity : 1 tablet per strip

Function : Other, Used to treat and prevent osteoporosis in postmenopausal women by increasing bone density and minimizing bone loss.

Ingredients : Ibandronic Acid

Terifrac 3 ml Cartridge 3N

Terifrac 3 ml Cartridge 3N

Origin of Medicine : Synthetic origin

Physical Form : Liquid

Recommended For : Patients with osteoporosis or severe bone loss

Quantity : 3 ml per cartridge

Function : Other, Boneforming agent; used for the treatment of osteoporosis

Ingredients : Teriparatide

Deninta SC 60 mg PFS

Deninta SC 60 mg PFS

Origin of Medicine : Biological

Physical Form : Other, Liquid Solution

Recommended For : Adults with osteoporosis or other bonerelated conditions

Quantity : 1 prefilled syringe (PFS)

Function : Used for the treatment of bone conditions such as osteoporosis, Other

Ingredients : Denosumab